1,485
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Dealing with calcification in the coronary arteries

, & ORCID Icon
Pages 237-240 | Received 19 Dec 2022, Accepted 28 Mar 2023, Published online: 31 Mar 2023

References

  • Lee S-E, Chang H-J, Sung JM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging. 2018;11:1475–1484. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S1936878X18303735
  • Budoff MJ, Bhatt DL, Kinninger A, et al. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020;41:3925–3932. InternetAvailable from. DOI:10.1093/eurheartj/ehaa652.
  • Vaidya K, Arnott C, Martínez GJ, et al. Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study. JACC Cardiovasc Imaging. 2018;11:305–316. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S1936878X1730791X
  • Lee J, Nakanishi R, Li D, et al. Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis. Am Heart J. 2018;206:127–130. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S0002870318302497
  • Win TT, Nakanishi R, Osawa K, et al. Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial). Am Heart J. 2019;212:129–133. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S0002870319300493
  • Aldana-Bitar J, Moore J, Manubolu VS, et al. Plaque progression differences between apixaban and rivaroxaban in patients with atrial fibrillation measured with cardiac computed tomography and plaque quantification. Am J Ther [Internet]. 9900; Available from: https://journals.lww.com/americantherapeutics/Fulltext/9900/Plaque_Progression_Differences_Between_Apixaban.88.aspx.
  • Post WS, Budoff M, Kingsley L, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014;160:458–467.
  • Vengrenyuk Y, Cardoso L, Weinbaum S. Micro-CT based analysis of a new paradigm for vulnerable plaque rupture: cellular microcalcifications in fibrous caps. Mol Cell Biomech. 2008;5:37–47.
  • Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110:3424–3429.
  • Mizukoshi M, Kubo T, Takarada S, et al. Coronary superficial and spotty calcium deposits in culprit coronary lesions of acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol. 2013;112:34–40. InternetAvailable from. DOI:10.1016/j.amjcard.2013.02.048.
  • Otsuka F, Sakakura K, Yahagi K, et al. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 2014;34:724–736. InternetAvailable from. DOI:10.1161/ATVBAHA.113.302642.
  • Hyuk-Jae C, Lf Y, Sang-Eun L, et al. Coronary atherosclerotic precursors of acute coronary syndromes. J Am Coll Cardiol. 2018;71:2511–2522. InternetAvailable from. DOI:10.1016/j.jacc.2018.02.079.
  • Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012;59:1592–1597. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S073510971200959X
  • Kataoka Y, Puri R, Hammadah M, et al. Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis. Cardiovasc Diagn Ther. 2014;4:460–469.
  • Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways. Circ Res. 2005;96:1248–1256. InternetAvailable from. DOI:10.1161/01.RES.0000171451.88616.c2.
  • Shi X, Gao J, Lv Q, et al. Calcification in atherosclerotic plaque vulnerability: friend or foe? Front Physiol. 2020;11:56.
  • Wang Y, Osborne MT, Tung B, et al. Imaging cardiovascular calcification. J Am Heart Assoc. 2018;7:e008564. InternetAvailable from. DOI:10.1161/JAHA.118.008564.
  • Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345.
  • Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018;39:2401–2408. InternetAvailable from. DOI:10.1093/eurheartj/ehy217.
  • Gi S, To G, Stephanie K, et al. Major global coronary artery calcium guidelines. JACC Cardiovasc Imaging. 2022;0. InternetAvailable from. doi:10.1016/j.jcmg.2022.06.018
  • Cury RC, Blankstein R, Leipsic J, et al. CAD-RADS™ 2.0 – 2022 coronary artery disease – reporting and data system an expert consensus document of the society of cardiovascular computed tomography (SCCT), the American college of cardiology (ACC), the American College of Radiology (ACR) and the North America society of cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr. 2022;4: United States; 2022.
  • Ns J, Rishi P, Todd A, et al. Effect of evolocumab on coronary plaque composition. J Am Coll Cardiol. 2018;72:2012–2021. InternetAvailable from. DOI:10.1016/j.jacc.2018.06.078.
  • Bergström G, Persson M, Adiels M, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144:916–929. InternetAvailable from. DOI:10.1161/CIRCULATIONAHA.121.055340.
  • Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;144:e368–454. InternetAvailable from. DOI:10.1161/CIR.0000000000001029.
  • Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64–70.
  • Yamamoto MH, Maehara A, Karimi Galougahi K, et al. Mechanisms of orbital versus rotational atherectomy plaque modification in severely calcified lesions assessed by optical coherence tomography. JACC: Cardiovasc Interv. 2017;10:2584–2586. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S1936879817320137
  • Abdel-Wahab M, Richardt G, Joachim Büttner H, et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (rotational atherectomy prior to taxus stent treatment for complex native coronary artery disease) trial. JACC Cardiovasc Interv. 2013;6(1):10–19. DOI:10.1016/j.jcin.2012.07.017
  • Nicholls SJ, Tuzcu EM, Wolski K, et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol. 2007;49:263–270. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S0735109706026556
  • Puri R, Nicholls SJ, Shao M, et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015;65:1273–1282. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S0735109715003010
  • Boden WE, O’rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516. InternetAvailable from. DOI:10.1056/NEJMoa070829.
  • De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991–1001. InternetAvailable from. https://doi.org/10.1056/NEJMoa1205361
  • A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360: 2503–2515. doi: 10.1056/NEJMoa0805796 InternetAvailable from.
  • Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–1407. InternetAvailable from. DOI:10.1056/NEJMoa1915922.
  • Mitchell JD, Fergestrom N, Gage BF, et al. Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol. 2018;72:3233–3242.
  • Cainzos-Achirica M, Miedema MD, McEvoy JW, et al. Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019. Circulation. 2020;141:1541–1553. InternetAvailable from. DOI:10.1161/CIRCULATIONAHA.119.045010.
  • Kalia NK, Cespedes L, Youssef G, et al. Motivational effects of coronary artery calcium scores on statin adherence and weight loss. Coron Artery Dis. 2015;26:225–230.
  • Taylor AJ, Bindeman J, Feuerstein I, et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008;51:1337–1341. InternetAvailable from https://www.sciencedirect.com/science/article/pii/S0735109708003240

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.